NCT03438279View on ClinicalTrials.gov

Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

June 23, 2015

Primary Completion Date

December 28, 2017

Study Completion Date

December 28, 2017

Conditions
Melanoma
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

02199

Local Institution, Boston

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03438279 - Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy | Biotech Hunter | Biotech Hunter